The Food and Drug Administration has approved a new drug that could prevent HIV infections with just two shots every year and ...

But the Trump administration’s cuts to HIV programs in the U.S. and abroad could undermine the drug’s rollout.

Clinical trials showed 99.9% of participants who received the drug, called Yeztugo​ from company Gilead Sciences, remained ...

A children’s cough syrup has been recalled due to the rick of it causing bacterial infection. According to the U.S. Food and ...

The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported ...

The drug could change the course of the AIDS epidemic. But the Trump administration has gutted the programs that might have ...

A federal judge has rejected a bid by compounding pharmacies to allow them to continue making copies of Novo Nordisk's ...

The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.

The initiative, referred to as the Commissioner's National Priority Voucher program, allows drug developers to participate in ...

Kraft Heinz will be pulling artificial dyes from its U.S. products starting in 2027 and will no longer roll out new products ...

Drugmaker Eli Lilly plans to buy Verve Therapeutics, a gene-editing startup, for about $1 billion upfront. The deal gives ...